J & J Arthritis Drug Sirukumab Raises Safety Concerns -FDA Staff J & J Arthritis Drug Sirukumab Raises Safety Concerns -FDA Staff

There were more deaths in patients taking Johnson and Johnson ' s experimental rheumatoid arthritis drug sirukumab than among those taking a placebo, staff reviewers for the U.S. Food and Drug Administration said in a report published Monday.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Pharmacist News Source Type: news